Dr. Wenge Xing 邢文阁
Chief Physician
Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Interventional minimally invasive treatment for benign and malignant tumors, including embolization for primary liver cancer, argon-helium cryoablation, particle implantation brachytherapy, hemangioma intervention, and vertebroplasty.
Dr. Xing has worked in interventional diagnosis and treatment since 1988. The doctor performs vascular and non-vascular procedures to manage tumors and complications, aiming to control disease progression and improve quality of life. Dr. Xing participates in research projects and clinical studies, and has published multiple academic papers.
Name order: in Chinese the family name comes first (Xing Wenge). Papers usually list the name as Wenge Xing or Xing W.
Selected publications
35 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2023 (senior author): Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study. PubMed 37180098
- Front Oncol, 2022 (senior author): Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer. PubMed 36072793
- Cancer Sci, 2021 (senior author): Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling. PubMed 34375482
- Curr Genet, 2021 (senior author): Diverse and conserved roles of the protein Ssu72 in eukaryotes: from yeast to higher organisms. PubMed 33244642
- Technol Cancer Res Treat, 2020 (senior author): Experimental Study on Evaluation of Blood Supply Level and Embolization Ratio of Liver Cancer Based on I-Flow Software. PubMed 33174500
- Cryobiology, 2018 (senior author): Immunological response induced by cryoablation against murine H22 hepatoma cell line in vivo. PubMed 29146066
- Zhonghua Yi Xue Za Zhi, 2010 (first author): [Percutaneous verterbreplasty combined with radiotherapy treating malignant vertebrate metastasis]. PubMed 20627018
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion